Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia

Short summary

New terms, 'host-associated alloimmune hemolytic anemia' and 'graft-associated alloimmune hemolytic anemia,' are proposed to distinguish hemolysis causes after ABO-incompatible HSCT, though their clinical utility may be limited by rarity.

AI-generated from the title and abstract; the full text is not read.